CClinicalTrials.gg
RecruitingNCT04963751Updated Aug 11, 2026

ERAS in Pediatric & Adolescent Gynecology Preoperative Counseling

An interventional study of Enhanced Recovery After Surgery (ERAS) Counseling to Patients and Enhanced Recovery After Surgery (ERAS) Counseling to Caregiver in Enhanced Recovery After Surgery and Gynecologic Disease, sponsored by University of Colorado, Denver. Recruiting at 1 site in United States. Open to female participants aged 9 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
9 Years to 17 Years
Sex
Female
01

Study summary

The Investigator propose a randomized trial that will assess whether participant involvement in pre-operative counseling for ERAS improves post-surgical pain scores. The Investigator will also assess participant compliance to ERAS-prescribed medications, and functionality (return to school). Each participant who is enrolled in the study will be assigned to 1) pre-operative counseling with participant's caregiver or 2) caregiver-only counseling.

Read the detailed description

Enhanced Recovery After Surgery (ERAS) protocols have been shown to be safe and effective in pediatric and adolescent gynecology (PAG) participants. However, the individual elements of ERAS that are associated with positive outcomes have not been identified. Pre-operative counseling and education is a standard component of ERAS. In pediatric and adolescent gynecology (PAG), pre-operative counseling is typically administered to the participant's caregiver rather than directly to the participant. It is possible that direct participant involvement in ERAS pre-operative counseling could be an important factor to improve post-surgical outcomes. To investigator's knowledge, no studies have examined the impact of direct participant involvement in pre-operative counseling on ERAS outcomes in the PAG population.

The Investigator propose a randomized trial that will assess whether participant involvement in pre-operative counseling for ERAS improves post-surgical pain scores. The Investigator will also assess participant compliance to ERAS-prescribed medications, and functionality (return to school). Each participant who is enrolled in the study will be assigned to 1) pre-operative counseling with participant's caregiver or 2) caregiver-only counseling.

02

Conditions studied

  • Enhanced Recovery After Surgery
  • Gynecologic Disease

Keywords

  • Gynecology
  • ERAS
  • Pediatrics
03

Who can participate

Ages eligible
9 Years to 17 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • 9- 17 years of age
  • Patient is undergoing abdominal surgery and being managed under the ERAS protocol

Exclusion criteria

Exclusion Criteria:

  • Developmental delay (IQ \< 70) determined by documentation in medical record
  • Emergency or non-elective surgical cases
  • Patients who attend clinic appointments independently from their caregiver
04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    pre-operative counseling with their caregiver

    Patients will be asked to attend a standard-of-care pre-operative teaching session with their parent.

    Other: Enhanced Recovery After Surgery (ERAS) Counseling to Patients

  • Placebo comparator
    caregiver-only counseling.

    Parents-only will attend a standard-of-care pre-operative teaching session.

    Other: Enhanced Recovery After Surgery (ERAS) Counseling to Caregiver

Interventions

  • OtherEnhanced Recovery After Surgery (ERAS) Counseling to Patients

    In pediatric and adolescent gynecology (PAG), pre-operative counseling is typically administered to the patient's caregiver rather than directly to the patient. It is possible that direct patient involvement in ERAS pre-operative counseling could be an important factor to improve post-surgical outcomes.

  • OtherEnhanced Recovery After Surgery (ERAS) Counseling to Caregiver

    In pediatric and adolescent gynecology (PAG), pre-operative counseling is typically administered to the patient's caregiver rather than directly to the patient. It is possible that direct patient involvement in ERAS pre-operative counseling could be an important factor to improve post-surgical outcomes.

05

What researchers measure

Primary outcomes

  1. Numeric Pain rating scores at post-op days 1 and 7

    Minimum value = 0, maximum value = 10. 0 = no pain at all, 10 = worst pain imaginable. A higher score on the rating scale indicates a worse outcome.

    Time frame: 1-7 days after surgery

Secondary outcomes

  1. Number of participants who have returned to school at 7-days post-op

    Yes/no question asking whether the participants has returned to school

    Time frame: 7 days after surgery

  2. Rate of medication adherence to ERAS-prescribed medications

    Participants reported adherence to ERAS medications during the post-operative period measured by asking patients which medications they are taking.

    Time frame: 1-7 days after surgery

  3. Rate of narcotic medication prescriptions

    Documentation of narcotic pain medications used during the post-operative period. Assessed via chart review of medical record.

    Time frame: 1-7 days after surgery

06

Study locations

1 of 1 sites recruiting
  • Pediatric and Gynecology Clinic at Children's Hospital Colorado
    Aurora, Colorado 80045, United States
    Recruiting
07

References and documents

08

Registry details

Key details

Study ID
NCT04963751
Lead sponsor
University of Colorado, Denver
Responsible party
Sponsor
First posted
Jul 15, 2021
Start date
Sep 8, 2022
Primary completion
Jan 31, 2028 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Aug 11, 2026

Study contacts

Patricia S Huguelet, MD
Contact
patricia.huguelet@cuanschutz.edu
(720)-777-2238
Jaime Laurin, MS
Contact
jaime.laurin@cuanschutz.edu
(720)-777-1375
Patricia Huguelet, MD
principal investigator · University of Colorado, Denver

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion